Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

Novo Nordisk Just Axed Its Deal with Hims & Hers. Should You Buy the Dip in HIMS Stock?

Hims & Hers (HIMS) shares tanked more than 30% on Monday after pharmaceutical behemoth Novo Nordisk (NVO) terminated its distribution agreement with the telehealth company. 

Novo Nordisk agreed to a high-profile partnership with HIMS to distribute Wegovy, its blockbuster weight-loss treatment. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.